国际皮肤性病学杂志    2006 32 (1): 23-25   ISSN: 2096-5540  CN: 32-1880/R   银屑病微血管异常增生机制及治疗对策 张彩萍, 崔盘根 中国医学科学院、中国协和医科大学皮肤病研究所, 南京210042 收稿日期 2005-05-30  修回日期 null  网络版发布日期 null 参考文献  [1] Detmar M.The role of VEGF and thrombospondins in skin angiogenesis.J Dermatol Sci,2000,24(Suppl 1):S78-S84. [2] Creamer D,Sullivan D,Bicknell R,et al.Angiogenesis in psoriasis.Angiogenesis,2002,5:231-236. [3] Xia YP,Li B,Hylton D,et al.Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis.Blood,2003,102:161-168. [4] Young HS,Summers AM,Bhushan M,et al.Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset.J Invest Dermatol,2004,122:209-215. [5] Kim HJ,Kim TY.Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes,differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C.Br J Dermatol,2005,152:418. [6] Kuroda K,Sapadin A,Shoji T,et al.Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis.J Invest Dermatol,2001,116:713-720. [7] Voskas D,Jones N,Van Slyke P,et al.A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.Am J Pathol,2005,166:843-855. [8] Li W,Tanaka K,Chiba Y,et al.Role of MMPs and plasminogen activators in angiogenesis after transmyocardial laser revascularization in dogs.Am J Physiol Heart Circ Physiol,2003,284:H23-30. [9] Weiss JB,McLaughlin B.Endothelial cell stimulating angiogenesis factor.Int J Biochem Cell Biol,1998,30:423-427. [10] Hotchkiss KA,Ashton AW,Schwartz EL.Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3.J Biol Chem,2003,278:19272-19279. [11] Longo R,Sarmiento R,Fanelli M,et al.Anti-angiogenic therapy:rationale,challenges and clinical studies.Angiogenesis,2002,5:237. [12] Sauder DN,Dekoven J,Champagne P,et al.Neovastat (AE-941),an inhibitor of angiogenesis:Randomized phase I/II clinical trial results in patients with plaque psoriasis.J Am Acad Dermatol,2002,47:535-541. [13] Beliveau R,Gingras D,Kruger EA,et al.The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.Clin Cancer Res,2002,8:1242-1250. [14] Deng H,Yan CL,Hu Y,et al.Photochemotherapy inhibits angiogenesis and induces apoptosis of endothelial cells in vitro.Photodermatol Photoimmunol Photomed,2004,20:191-199. [15] Diaz BV,Lenoir MC,Ladoux A,et al.Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids.J Biol Chem,2000,275:642-650. [16] Hernandez GL,Volpert OV,Iniguez MA,et al.Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A:roles of the nuclear factor of activated T cells and cyclooxygenase 2.J Exp Med,2001,193:607-620. [17] Fraser AD,van Kuijk AW,Westhovens R,et al.A randomised,double blind,placebo controlled,multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis.Ann Rheum Dis,2005,64:859-864. [18] Goedkoop AY,Kraan MC,Picavet DI,et al.Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy:a prospective single-centre study.Arthritis Res Ther,2004,6:R326-R334. [19] Canete JD,Pablos JL,Sanmarti R,et al.Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis.Arthritis Rheum,2004,50:1636-1641. 通讯作者: